BioSpace News Archive

Aquestive Therapeutics, Inc. announced today that the management team will participate in the 2023 Wedbush PacGrow Healthcare Conference in New York.

Candel Therapeutics, Inc. today announced that Paul Peter Tak, MD, PhD, FMedSci, President and Chief Executive Officer, will participate in a fireside chat at the upcoming Canaccord Genuity 43rd Annual Growth Conference, taking place August 7-10, 2023, in Boston.

ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, will hold a conference call on Thursday, August 10, 2023, at 11:00 a.m. Eastern time to discuss its results for the second quarter ended June 30, 2023 and provide a business update.

Enlivex Therapeutics Ltd. today announced the peer-reviewed publication of clinical and exploratory data from a Phase Ib and a Phase IIa clinical trial in Frontiers in Immunology.

NeuroBo Pharmaceuticals, Inc. today announced that it has entered into a term sheet with MThera Pharma Co., Ltd. (MTHERA) which provides for the terms under which NeuroBo will out-license the worldwide rights, outside of Korea, for NB-01 for the treatment of painful diabetic neuropathy to MTHERA.

VivoSense, Inc. (“VivoSense”) is thrilled to announce Colin Bower as our new Chief Executive Officer and a member of our Board of Directors. Bower will succeed Dudley Tabakin, who will work closely with Bower to achieve a seamless transition. Tabakin will continue with VivoSense in his new capacity as Chief Product Officer.

CG Oncology, Inc. announced the close of an oversubscribed $105 million crossover financing round, co-led by new investors Foresite Capital and TCGX, with participation from Avidity Partners, BVF Partners and Janus Henderson Investors, as well as existing investors including Acorn Bioventures, Ally Bridge Group, Decheng Capital, Longitude Capital, Malin Corporation and RA Capital Management.

Lantern Pharma Inc. today announced that it will host its second quarter 2023 operating and financial results webcast on Wednesday, August 9, 2023.

LENSAR, Inc. today announced that the Company’s second quarter 2023 financial results will be released before market open on Wednesday, August 9, 2023.

Sierra Space announced it has developed a pathfinder spaceflight investigation in collaboration with BioServe Space Technologies and other partners to grow hematopoietic stem cells in microgravity to better help patients on Earth undergoing treatment for blood cancer.